We report the results of a prospective, randomised con trolled, 24 week trial to assess the efficacy of oral tetra cycline and oral tetracycline with topical prednisolone in the treatment of recalcitrant recurrent corneal erosions, i.e. those which fail to respond to standard therapy. A total of 30 patients were randomly allocated to either standard treatment (group A), standard treatment and oral tetracycline (group B) or standard treatment, oral tetracycline and topical prednisolone (group C). Treat ment groups Band C were instructed to perform daily lid hygiene. There was a significant reduction in the number of recurrent corneal erosions during the 24 week study period in group B (p = 0.04) and in group C (p = 0.0003) but not in group A (p = 0.66). There was a significant difference in the accelerated healing time of recurrent corneal microerosions between groups A and B (p = 0.001) and between groups A and C (p = 0.001).
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SUMMARY
We report the results of a prospective, randomised con trolled, 24 week trial to assess the efficacy of oral tetra cycline and oral tetracycline with topical prednisolone in the treatment of recalcitrant recurrent corneal erosions, i.e. those which fail to respond to standard therapy. A total of 30 patients were randomly allocated to either standard treatment (group A), standard treatment and oral tetracycline (group B) or standard treatment, oral tetracycline and topical prednisolone (group C). Treat ment groups Band C were instructed to perform daily lid hygiene. There was a significant reduction in the number of recurrent corneal erosions during the 24 week study period in group B (p = 0.04) and in group C (p = 0.0003) but not in group A (p = 0.66). There was a significant difference in the accelerated healing time of recurrent corneal microerosions between groups A and B (p = 0.001) and between groups A and C (p = 0.001).
There was a significant improvement in the symptom scores during the study in treatment groups B and C (p = 0.005) but not in group A (p = 0.15). We conclude that lid hygiene and oral oxytetracycline 250 mg twice daily for 12 weeks with or without topical prednisolone for the first 7 days is beneficial in the management of recalcitrant recurrent corneal erosions.
Recurrent corneal erosion is a relatively common dis order, characterised by repeated episodes of early morning symptoms, with pain, difficulty opening the eyes, water ing and photophobia. I , 2 The treatment of recurrent corneal erosions is difficult. The vast majority of patients respond to conventional therapy with topical lubricating ointment at night and patching in the acute stages.3 There is a small group of patients, however, who fail to respond to conven tional therapy. We have introduced the term 'recalcitrant recurrent corneal erosions' for that group of patients who continue to suffer recurrent corneal erosions in spite of Over a period of time we have observed extensive mei bomian gland dysfunction in patients with recurrent cor neal erosions. The purpose of this study was to evaluate in patients with recalcitrant recurrent corneal erosions the effect of treatment of meibomian gland dysfunction on (I) the rate of recurrent corneal erosions, (2) the symptoms in the recurrent corneal erosion syndrome and (3) the rate of healing of recurrent corneal erosions.
MATERIALS AND METHODS
The details of patient examination and clinical features are reported elsewhere.s
Materials
Standard treatment was defined as the following: (1) Simple eye ointment every night. (2) A macroerosion was treated with a single dose of preservative-free guttae (g) cyclopentolate I % and g chloramphenicol, followed by patching for 24 hours and analgesia as required. (3) If the corneal epithelium was wrinkled and mobile and lying loosely over the underlying stroma, manual debridement of the corneal epithelium was performed.
Treatment with tetracycline consisted of 12 weeks of oral oxytetracycline 250 mg twice daily (b.d.). Preser vative-free g prednisolone 0.5% four times daily (q.i.d.) was given for 7 days only. Lid hygiene involved the use of hot compresses for 5-10 minutes followed by lid cleaning using a moistened cotton-wool bud along the lid margins to remove debris from the lids and eyelashes.
Patient Selection and Entry
This study was approved by the Ethical Review Bo ard at the Bi rmingham and Midland Eye Hospital. All patients gave written informed consent prior to study entry.
Exclusion criteria included: (1) any contraindication to oral tetracycline therapy, (2) previous treatment with oral (3) any concurrent ocular medication other than the study drugs.
Study Design
This was a single-centre randomised controlled study. At the initial study visit patients were randomised to one of three groups, using random number tables. All patients received standard therapy as detailed above for the entire 24 week study period. Group A was the control group. Group B was allocated to receive oral oxytetracycline 250 mg b.d. for the first 12 weeks of the study. Group C received preservative-free g prednisolone q.i.d. for 7 days at the commencement of the study and oral oxytetra cycline 250 mg b.d. for the first 12 weeks of the study. Groups B and C were also instructed to perform daily lid hygiene (Table I) .
At the initial study visit each patient was instructed in the use of a visual analogue scale. There were three symp tom indices: pain, light sensitivity and watering. The visual analogue scale was an uncalibrated 10 cm line, which patients were instructed to cross to indicate the sev erity of symptoms for the preceding week. The right-hand side of the line represented the most severe symptoms and the left-hand side the least severe symptoms. A symptom score sheet was given for each week and patients were instructed to complete the symptom sheet on a weekly basis. They were also instructed to record the number of recurrent corneal erosions for that week and the duration of each recurrent corneal erosion.
Study visits thereafter were performed at 4, 12 and 24 weeks following study entry. At each review visit the number, type and duration of recurrent corneal erosions for the preceding time interval was documented. The symptom score sheets were collected. At each study visit the patients were given an appropriate number of score sheets to complete prior to the next visit.
Statistical Methods
For each group, repeated measures analysis of variance investigated the changes in the number of erosions over the 24 week study period by comparing the number of ero sions at each week and adjusting for the correlation between data from different weeks. Changes in the symp tom scores over this period were analysed in an identical fashion. The Mann-Whitney test was used to compare any improvements in the healing time of recurrent corneal ero sions between groups A, B and C.
RESULTS
The results of this study demonstrating the effect of treat ment of recurrent corneal erosions are shown in Tables  II-IV Thirty patients were entered in the study. In group B, 1 patient discontinued oral tetracycline after 6 weeks of treatment, but he continued to attend for assessment and was analysed on an intention-to-treat basis. Twenty-nine patients completed the study per protocol and 30 patients are included in the analysis.
The demographics of the 30 patients analysed are shown in Table II . There were no statistically significant differences observed between the groups with regard to age, gender and recurrent corneal erosion history. The mean duration of symptoms was 5.3 years (range 0.4-47 years).
Recurrent Corneal Erosions
The number of recurrent corneal erosions, both micro erosions and macroerosions, for each week of the 24 week study period was evaluated for each group. Using repeated measures analysis of variance, there was found to be a sig nificant reduction in the number of erosions during the 24 week study period in group B (p = 0.04) and in group C (p = 0.0003) but not in group A (p = 0.66). The results are illustrated in Fig. 1 .
A similar change was seen when the number of recur rent corneal microerosions was evaluated. During the course of the study, from commencement to 24 weeks, there was a significant reduction in the number of micro erosions in group B (p = 0.04) and in group C (p = 0.0003) but not in group A (p = 0.76) (repeated measures analysis of variance). The results are illustrated in Fig. 2 .
During the 24 week study period there was a total of 11 recurrent corneal macroerosions in group A, 2 in group B and 3 in group C. The difference between the three groups did not reach statistical significance, however, due to the small numbers involved (Table III) . The healing time of recurrent corneal microerosions at the commencement of the study was compared with the healing time at the completion of the study. There was an acceleration in the healing time of microerosions in group B and in group C but not in group A. There was a signifi cant difference in the accelerated rate of healing in group B compared with group A (p = 0.001) and group C com pared with group A (p = 0.00 I), but not between groups B and C (p = 0.07) (Mann-Whitney test). The results are shown in Table IV .
The symptom scores for pain, photophobia and lac rimation were summed for each week and the decrease in scores from baseline to completion was examined. The mean symptom scores at the commencement of the study were 9.27 in group A and 10.26 in groups Band C. At the completion of the study at week 24, the mean symptom scores were 6.6 in group A and 1.8 in groups Band C. At the completion of the study at week 24, the mean symptom scores measured 6.6 in group A and 1.8 in groups B and C. Repeated measures analysis of variance showed a statis- 
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tic ally significant decrease in symptom scores in groups B and C (p = 0.005) but not in group A (p = 0.15).
No patients required epithelial debridement during the study. Two patients complained of slight alteration of bowel habit following commencement of oral oxytetra cycline and this resolved within a few days with no seque lae. No other side-effects were reported.
DISCUSSION
The management of recurrent corneal erosions can be one of the most frustrating experiences in an ophthal mologist's practice. Delayed epithelialisation, persistent sloughing of the newly formed epithelium and recurrent episodes of epithelial loss are common problems. The ulti mate cure has remained elusive. The mainstay of standard prophylactic treatment is lubricating eye ointment instilled at night, combined with epithelial debridement, if indicated. 3.6 Various lubricating agents have been used: methylcel lulose drops, 10% boric ointment, 5% hypertonic saline and liquid paraffin. The prevention of attacks is probably due to the oily film of ointment on the corneal surface which reduces contact of the corneal epithelium with the lids and tear film.
Epithelial debridement was first described in 1906 by Franke,7 who combined mechanical debridement with chemical cautery using chlorine water. In addition to chlo rine water, trichloroacetic acid, phenol and iodine have been used for chemical cauterisation. controlled studies evaluating epithelial debridement in the management of recurrent corneal erosions.
We believe that corneal epithelial debridement is indi cated only if the epithelium is wrinkled and freely mobile over the underlying stroma. We also believe that chemical cautery should not be performed due to the risk of scar for mation. The corneal epithelium should be removed with out disturbance of the underlying Bo wman's layer in an effort to avoid corneal scarring.
Therapeutic contact lenses, anterior stromal puncture, topical steroids and surface diathermy and recently excimer laser have all been used with varying degrees of success in patients with recalcitrant recurrent corneal ero sions.12-15 These therapeutic manoeuvres are potentially associated with severe side-effects, including infection, corneal vascularisation and scarring, with subsequent impairment of vision. None of these approaches has cured the problem of recurrent corneal erosions.
In this study, we treated a group of patients suffering from recalcitrant recurrent corneal erosions. All had failed to respond to standard therapy. Treatment with lid hygiene and oral oxytetracycline 250 mg for 12 weeks resulted in a significant improvement in the control of recalcitrant recurrent corneal erosions. In spite of the relatively small numbers in each group, patients in the treatment groups had significantly fewer recurrent corneal erosions (group B, p = 0.04; group C, p = 0.003), the healing time of ero sions was significantly accelerated (group B, p = 0.00 I; group C, p = 0.001) and symptoms improved (groups B and C, p = 0.005) compared with a control group. We were unable to find a significant difference between the group treated with topical prednisolone and tetracycline and those receiving tetracycline alone. The pathogenesis of recurrent corneal erosions is poorly understood.12.16 Patients frequently present following a superficial injury to the cornea. Other types of injury, such as chemical injuries, bacterial and viral corneal infections, have also been implicated. A history of trauma is not, how ever, invariable.17 Recurrent corneal erosions can occur secondary to a number of corneal dystrophies. 2 The corneal epithelium is normally firmly attached to basement membrane, which is adherent to Bo wman's layer. Hemidesmosomes are anchoring fibrils which attach the epithelial basement membrane to Bo wman's layer and to the underlying stroma. Following a superficial injury to the cornea, epithelial migration and multiplica tion occurs and the corneal epithelium forms new base ment membrane and hemidesmosomes.IH The restoration of maximum adhesion of the corneal epithelium to the underlying stroma takes 8 weeks.19 This normal healing process is disrupted in the syndrome of recurrent corneal erosions. 20 Histopathological examination in recurrent corneal ero sions reveals abnormalities of the corneal epithelium, basement membrane and hemidesmosomes.21,22 The cor neal epithelium contains pale, swollen basal epithelial cells. Pseudocystic collections of cellular and amorphous debris are found within the epithelium and are thought to be due to entrapment of epithelium by aberrant basement membrane. The basement membrane is multi laminar, thickened and may be focally absent. Sheets of aberrant basement membrane may be found within the epithelium. Ultrastructural analysis reveals localised absence of hemidesmosomes. 23 One theory to explain recurrent corneal erosions is that abnormal corneal epithelium results in abnormal hemidesmosome-basement membrane adhesion com plexes.1,16 There is periodic 'lift off' of the corneal epi thelium which allows debris to accumulate subepithelially, providing an inadequate substrate for already defective basement membrane. The cycle is self perpetuating. Separation of the corneal epithelium is more prone to occur at night. Tears become relatively hypotonic at night due to reduced evaporation, and superficial cor neal odema may develop. It is thought that suction of the lids on opening results in tearing of the fragile epithelial attachments, which have been weakened by the associated odema.1
We believe that meibomian gland dysfunction is a caus ative factor in the pathogenesis of recurrent corneal ero sions, based on a number of observations. (1) Superficial corneal injuries cause recurrent corneal erosions in some patients and no sequelae in others, so there must be some underlying ocular abnormality in those patients develop ing recurrent corneal erosions. (2) The commonest site of recurrent corneal erosions is not at the site of original trauma but the inferior cornea, that part of the cornea which has maximum contact with the tear film. 12 (3) We evaluated a group of patients with recalcitrant recurrent erosions and found extensive meibomian gland dysfunc tion in all patients as manifest by: dropout and inspissation of meibomian glands. reduced tear film break-up time in the presence of a normal aqueous component, injection of the conjunctival blood vessels and accompanying facial cutaneous changes.5 (4) This study has shown that treat ment of meibomian gland dysfunction alleviates the syn drome of recalcitrant recurrent corneal erosions.
The meibomian glands secrete the most anterior zone of the tear film, a lipid layer which enhances tear film stab ility and prevents evaporation of the preocular tear film. 24 Increased quanti ties of fatty acids have been demonstrated in the tears of patients with meibomian gland dysfunc tion. 25 It is possible that these fatty acids could interfere with the normal healing of corneal epithelium and the for mation of hemidesmosomes which then causes the syn drome of recurrent corneal erosions.
Oral tetracycline administered in low doses is effective in the management of meibomian gland dysfunction. Our understanding of the exact mechanism by which tetra cycline is effective in the treatment of meibomian gland dysfunction is limited as it has a variety of actions. Tetra cycline may act by inhibition of the production of extra cellular enzymes by the ocular flora or inhibition of the synthesis of lipids by meibomian glands.26.27 Tetracycline also has an anti-inflammatory action independent of the antimicrobial effects and has been shown to bind to con junctiva and the goblet cells.2s
